These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 19055665)

  • 1. Longitudinal follow up of elevated pulmonary artery pressures in children with sickle cell disease.
    Pashankar FD; Carbonella J; Bazzy-Asaad A; Friedman A
    Br J Haematol; 2009 Mar; 144(5):736-41. PubMed ID: 19055665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and risk factors of elevated pulmonary artery pressures in children with sickle cell disease.
    Pashankar FD; Carbonella J; Bazzy-Asaad A; Friedman A
    Pediatrics; 2008 Apr; 121(4):777-82. PubMed ID: 18381543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteinuria is associated with elevated tricuspid regurgitant jet velocity in children with sickle cell disease.
    Forrest S; Kim A; Carbonella J; Pashankar F
    Pediatr Blood Cancer; 2012 Jun; 58(6):937-40. PubMed ID: 21990235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevation of tricuspid regurgitant jet velocity, a marker for pulmonary hypertension in children with sickle cell disease.
    Ambrusko SJ; Gunawardena S; Sakara A; Windsor B; Lanford L; Michelson P; Krishnamurti L
    Pediatr Blood Cancer; 2006 Dec; 47(7):907-13. PubMed ID: 16496290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary hypertension as a risk factor for death in patients with sickle cell disease.
    Gladwin MT; Sachdev V; Jison ML; Shizukuda Y; Plehn JF; Minter K; Brown B; Coles WA; Nichols JS; Ernst I; Hunter LA; Blackwelder WC; Schechter AN; Rodgers GP; Castro O; Ognibene FP
    N Engl J Med; 2004 Feb; 350(9):886-95. PubMed ID: 14985486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal study of echocardiography-derived tricuspid regurgitant jet velocity in sickle cell disease.
    Desai PC; May RC; Jones SK; Strayhorn D; Caughey M; Hinderliter A; Ataga KI
    Br J Haematol; 2013 Sep; 162(6):836-41. PubMed ID: 23829561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary hypertension in children and young adults with sickle cell disease: evidence for familial clustering.
    Dahoui HA; Hayek MN; Nietert PJ; Arabi MT; Muwakkit SA; Saab RH; Bissar AN; Jumaa NM; Farhat FS; Dabbous IA; Bitar FF; Abboud MR
    Pediatr Blood Cancer; 2010 Mar; 54(3):398-402. PubMed ID: 19827138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paediatric sickle cell disease: pulmonary hypertension but normal vascular resistance.
    Chaudry RA; Cikes M; Karu T; Hutchinson C; Ball S; Sutherland G; Rosenthal M; Bush A; Crowley S
    Arch Dis Child; 2011 Feb; 96(2):131-6. PubMed ID: 21030373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Misclassification of pulmonary hypertension in adults with sickle hemoglobinopathies using Doppler echocardiography.
    Fitzgerald M; Fagan K; Herbert DE; Al-Ali M; Mugal M; Haynes J
    South Med J; 2012 Jun; 105(6):300-5. PubMed ID: 22665152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated tricuspid regurgitant velocity as a marker for pulmonary hypertension in children with sickle cell disease: less prevalent and predictive than previously thought?
    Hebson C; New T; Record E; Oster M; Ehrlich A; Border W; James-Herry A; Kanaan U
    J Pediatr Hematol Oncol; 2015 Mar; 37(2):134-9. PubMed ID: 24942020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors and mortality associated with an elevated tricuspid regurgitant jet velocity measured by Doppler-echocardiography in thalassemia: a Thalassemia Clinical Research Network report.
    Morris CR; Kim HY; Trachtenberg F; Wood J; Quinn CT; Sweeters N; Kwiatkowski JL; Thompson AA; Giardina PJ; Boudreaux J; Olivieri NF; Porter JB; Neufeld EJ; Vichinsky EP;
    Blood; 2011 Oct; 118(14):3794-802. PubMed ID: 21772051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary hypertension in sickle cell disease children under 10 years of age.
    Colombatti R; Maschietto N; Varotto E; Grison A; Grazzina N; Meneghello L; Teso S; Carli M; Milanesi O; Sainati L
    Br J Haematol; 2010 Sep; 150(5):601-9. PubMed ID: 20553267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective appraisal of pulmonary hypertension in children with sickle cell disease.
    Sedrak A; Rao SP; Miller ST; Hekmat V; Rao M
    J Pediatr Hematol Oncol; 2009 Feb; 31(2):97-100. PubMed ID: 19194191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association between tricuspid regurgitation velocity and 5-year survival in a North West London population of patients with sickle cell disease in the United Kingdom.
    Cabrita IZ; Mohammed A; Layton M; Ghorashian S; Gilmore A; Cho G; Howard J; Anie KA; Desforges L; Bassett P; Grapsa J; Howard L; Mahalingam G; Dawson D; Pinto FJ; Nihoyannopoulos P; Davies SC; Gibbs JS
    Br J Haematol; 2013 Aug; 162(3):400-8. PubMed ID: 23713628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A modified noninvasive screening protocol for pulmonary hypertension in children with sickle cell disease-Who should be sent for invasive evaluation?
    Lilje C; Harry J; Gajewski KK; Gardner RV
    Pediatr Blood Cancer; 2017 Nov; 64(11):. PubMed ID: 28475298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary hypertension in children and adolescents with sickle cell disease.
    Onyekwere OC; Campbell A; Teshome M; Onyeagoro S; Sylvan C; Akintilo A; Hutchinson S; Ensing G; Gaskin P; Kato G; Rana S; Kwagyan J; Gordeuk V; Williams J; Castro O
    Pediatr Cardiol; 2008 Mar; 29(2):309-12. PubMed ID: 17680298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longitudinal effect of disease-modifying therapy on tricuspid regurgitant velocity in children with sickle cell anemia.
    Rai P; Joshi VM; Goldberg JF; Yates AM; Okhomina VI; Penkert R; Ataga KI; Kang G; Hankins JS
    Blood Adv; 2021 Jan; 5(1):89-98. PubMed ID: 33570630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum apelin as a novel non-invasive marker for subclinical cardiopulmonary complications in children and adolescents with sickle cell disease.
    Elbarbary NS; Ismail EA; Roushdy A; Fahmy E
    Blood Cells Mol Dis; 2016 Mar; 57():1-7. PubMed ID: 26852648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exercise-Induced Abnormal Increase of Systolic Pulmonary Artery Pressure in Adult Patients With Sickle Cell Anemia: An Exercise Stress Echocardiography Study.
    de Lima-Filho NN; Figueiredo MS; Vicari P; Cançado R; Carvalho AC; Bordin JO; Campos O
    Echocardiography; 2016 Dec; 33(12):1880-1890. PubMed ID: 25521187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysregulated arginine metabolism and cardiopulmonary dysfunction in patients with thalassaemia.
    Morris CR; Kim HY; Klings ES; Wood J; Porter JB; Trachtenberg F; Sweeters N; Olivieri NF; Kwiatkowski JL; Virzi L; Hassell K; Taher A; Neufeld EJ; Thompson AA; Larkin S; Suh JH; Vichinsky EP; Kuypers FA;
    Br J Haematol; 2015 Jun; 169(6):887-98. PubMed ID: 25907665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.